• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人糖皮质激素受体配体结合域的结晶:迈向选择性糖皮质激素的一步。

Crystallization of the human glucocorticoid receptor ligand binding domain: a step towards selective glucocorticoids.

作者信息

Necela Brian M, Cidlowski John A

机构信息

Laboratory of Signal Transduction, Building 101, MD F3-07, Department of Health and Human Services, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709, USA.

出版信息

Trends Pharmacol Sci. 2003 Feb;24(2):58-61. doi: 10.1016/S0165-6147(02)00046-9.

DOI:10.1016/S0165-6147(02)00046-9
PMID:12559765
Abstract

The crystal structure of the glucocorticoid receptor (GR) ligand binding domain in a ternary complex with dexamethasone and a TIF2 coactivator peptide has been determined recently. The structure reveals several distinct features not found in other nuclear receptors, such as a novel dimerization interface and a second charge clamp that might be important in determining coactivator binding selectivity. The GR ligand binding domain also has a steroid binding pocket that is distinct from other nuclear receptors and might explain its selectivity for glucocorticoids and its diversity of responses.

摘要

最近已确定了糖皮质激素受体(GR)配体结合域与地塞米松和一种TIF2共激活剂肽形成的三元复合物的晶体结构。该结构揭示了其他核受体中未发现的几个独特特征,例如一个新的二聚化界面和第二个电荷钳,这可能在确定共激活剂结合选择性方面很重要。GR配体结合域还有一个与其他核受体不同的类固醇结合口袋,这可能解释了其对糖皮质激素的选择性及其反应的多样性。

相似文献

1
Crystallization of the human glucocorticoid receptor ligand binding domain: a step towards selective glucocorticoids.人糖皮质激素受体配体结合域的结晶:迈向选择性糖皮质激素的一步。
Trends Pharmacol Sci. 2003 Feb;24(2):58-61. doi: 10.1016/S0165-6147(02)00046-9.
2
Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition.糖皮质激素受体配体结合域的晶体结构揭示了受体二聚化和共激活因子识别的新模式。
Cell. 2002 Jul 12;110(1):93-105. doi: 10.1016/s0092-8674(02)00817-6.
3
Structure and function of the glucocorticoid receptor ligand binding domain.糖皮质激素受体配体结合域的结构与功能
Vitam Horm. 2004;68:49-91. doi: 10.1016/S0083-6729(04)68002-2.
4
Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction.通过糖皮质激素受体进行的配体选择性反式激活和反式抑制:辅因子相互作用的作用
Mol Cell Endocrinol. 2009 Feb 27;299(2):219-31. doi: 10.1016/j.mce.2008.10.008. Epub 2008 Oct 19.
5
First High-Resolution Crystal Structures of the Glucocorticoid Receptor Ligand-Binding Domain-Peroxisome Proliferator-Activated Coactivator 1- Complex with Endogenous and Synthetic Glucocorticoids.糖皮质激素受体配体结合域-过氧化物酶体增殖物激活受体共激活因子 1 复合物与内源性和合成糖皮质激素的首个高分辨率晶体结构。
Mol Pharmacol. 2019 Oct;96(4):408-417. doi: 10.1124/mol.119.116806. Epub 2019 Aug 7.
6
Modelling the glucocorticoid receptor and producing therapeutic agents with anti-inflammatory effects but reduced side-effects.对糖皮质激素受体进行建模,并研发出具有抗炎作用但副作用较小的治疗药物。
Exp Physiol. 2007 Mar;92(2):299-309. doi: 10.1113/expphysiol.2006.036194. Epub 2006 Nov 30.
7
Glucocorticoid receptor homodimers and glucocorticoid-mineralocorticoid receptor heterodimers form in the cytoplasm through alternative dimerization interfaces.糖皮质激素受体同二聚体和糖皮质激素 - 盐皮质激素受体异二聚体通过交替的二聚化界面在细胞质中形成。
Mol Cell Biol. 2001 Feb;21(3):781-93. doi: 10.1128/MCB.21.3.781-793.2001.
8
X-ray crystal structure of the novel enhanced-affinity glucocorticoid agonist fluticasone furoate in the glucocorticoid receptor-ligand binding domain.新型增强亲和力糖皮质激素激动剂糠酸氟替卡松在糖皮质激素受体-配体结合域中的X射线晶体结构
J Med Chem. 2008 Jun 26;51(12):3349-52. doi: 10.1021/jm800279t. Epub 2008 Jun 4.
9
Structural Analysis of the Glucocorticoid Receptor Ligand-Binding Domain in Complex with Triamcinolone Acetonide and a Fragment of the Atypical Coregulator, Small Heterodimer Partner.与曲安奈德和非典型共调节因子小异二聚体伴侣片段结合的糖皮质激素受体配体结合域的结构分析
Mol Pharmacol. 2017 Jul;92(1):12-21. doi: 10.1124/mol.117.108506. Epub 2017 Apr 10.
10
Molecular basis of the interaction specificity between the human glucocorticoid receptor and its endogenous steroid ligand cortisol.人类糖皮质激素受体与其内源性甾体配体皮质醇之间相互作用特异性的分子基础。
Chembiochem. 2005 Jun;6(6):1110-8. doi: 10.1002/cbic.200400361.

引用本文的文献

1
The Role of Conformational Dynamics and Allostery in the Control of Distinct Efficacies of Agonists to the Glucocorticoid Receptor.构象动力学和变构作用在控制激动剂对糖皮质激素受体不同效能中的作用
Front Mol Biosci. 2022 Jul 7;9:933676. doi: 10.3389/fmolb.2022.933676. eCollection 2022.
2
Homeostatic Regulation of Glucocorticoid Receptor Activity by Hypoxia-Inducible Factor 1: From Physiology to Clinic.糖皮质激素受体活性的稳态调控:由缺氧诱导因子 1 介导——从生理学到临床。
Cells. 2021 Dec 7;10(12):3441. doi: 10.3390/cells10123441.